Company profile
Cyclis Pharmaceuticals company profile
Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.
Business identity
- Website
- http://www.cyclispharma.com/
- Contact email
- [email protected]
- Phone number
- +44 1223 354118
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $0-$1M
- Founded
- 2001-01-01, Year
Headquarters
- Headquarters
- Cissna Park, Illinois, United States
- Postal code
- 02062
- Country code
- US
- Continent
- North America